IMC Chicago
INDV icon

IMC Chicago’s Indivior Pharmaceuticals INDV Stock Holding History

IMC Chicago’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,723
Closed -$389K – 6550
2026
Q1 		$327K Sell
10,723
-9,229
-46% -$305K ﹤0.01% 4495
2025
Q4 		$716K Buy
+19,952
New +$609K ﹤0.01% 3235

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

IMC Chicago's INDV Position: Q2 2026 in Review

IMC Chicago sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 10,723 shares — an estimated $389K sold.

IMC Chicago first reported a position in INDV in Q4 2025 and held it in 2 quarters. The position peaked at $716K in Q4 2025. 136 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • IMC Chicago reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 10,723 Indivior Pharmaceuticals shares in Q2 2026, an estimated $389K.
  • IMC Chicago first reported a position in Indivior Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • IMC Chicago's Indivior Pharmaceuticals position peaked at $716K in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.